for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AmerisourceBergen Corp.

ABC.N

Latest Trade

106.80USD

Change

1.16(+1.10%)

Volume

2,204,182

Today's Range

104.53

 - 

107.84

52 Week Range

72.20

 - 

112.45

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
105.64
Open
105.60
Volume
2,204,182
3M AVG Volume
23.32
Today's High
107.84
Today's Low
104.53
52 Week High
112.45
52 Week Low
72.20
Shares Out (MIL)
204.69
Market Cap (MIL)
21,861.21
Forward P/E
12.71
Dividend (Yield %)
1.65

Next Event

Q1 2021 AmerisourceBergen Corp Earnings Release

Latest Developments

More

Amerisourcebergen Sees FY 2021 Adjusted Earnings Per Share $8.25 To $8.50

AmerisourceBergen And Walgreens Boots Alliance Announce Strategic Transaction

Lilly's Neutralizing Antibody Receives FDA Emergency Use Nod For Treatment Of Recently Diagnosed COVID-19

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About AmerisourceBergen Corp.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.

Industry

Biotechnology & Drugs

Contact Info

1300 Morris Dr

CHESTERBROOK, PA

19087-5594

United States

+1.610.7277000

Executive Leadership

Steven H. Collis

Chairman of the Board, President, Chief Executive Officer

James F. Cleary

Chief Financial Officer, Executive Vice President

Silvana Battaglia

Chief Human Resource Officer, Executive Vice President

Gina K. Clark

Executive Vice President, Chief Communications & Administration Officer

John G. Chou

Executive Vice President, Chief Legal Officer and Secretary

Key Stats

2.32 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

167.9K

2019

179.6K

2020

189.9K

2021(E)

200.4K
EPS (USD)

2018

6.490

2019

7.090

2020

7.900

2021(E)

8.403
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.12
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-34.48
Return on Equity (TTM)
-8.15

Latest News

Latest News

Walgreens maintains full-year profit growth forecast; shares rise

Walgreens Boots Alliance Inc said on Thursday it expects benefits from COVID-19 vaccinations to cushion the impact of pandemic-induced restrictions, and stuck to its full-year earnings growth forecast, sending its shares up 7%.

AmerisourceBergen to buy Walgreens' distribution unit in $6.5 billion Europe push

U.S. drug wholesaler AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business for $6.5 billion to expand in Europe as well as to compete better in the U.S. healthcare sector.

REFILE-AmerisourceBergen to buy Walgreens' distribution business in $6.5 bln deal

Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.

Moderna COVID-19 vaccine distribution started in Canada by FedEX, Innomar Strategies

FedEx Corp's Canadian subsidiary and Innomar Strategies, a Canada-based unit of U.S. drug distributor AmerisourceBergen Corp said on Thursday they have started to distribute Moderna Inc's COVID-19 vaccine across Canada.

Washington state judge finds AmerisourceBergen in contempt in opioid case

A judge in Washington state has found drug distributor AmerisourceBergen in contempt for failing to turn over records from its board or make key witnesses available to testify in a lawsuit by the state alleging it fueled the opioid crisis.

McKesson says potential opioid settlement proposal raised to up to $21 bln

McKesson Corp and two other drug distributors could be expected pay up to $21 billion for the potential settlement of lawsuits alleging the companies fueled the U.S. opioid epidemic, the company said on Tuesday.

AmerisourceBergen must face derivative suit over contaminated chemo drugs

Drug wholesaler AmerisourceBergen Corp and some of its executives and directors must face a shareholder lawsuit over its sale of unsterile chemotherapy drugs and payments of kickbacks to doctors, which have already resulted in $885 million in criminal and civil penalties...

BRIEF-U.S. States Seek $26.4 Bln From Drug Companies In Opioid Litigation - WSJ

* U.S. STATES SEEK $26.4 BILLION FROM DRUG COMPANIES IN OPIOID LITIGATION- WSJ

BRIEF-Amerisourcebergen Selected By Deciphera Pharmaceuticals To Support Qinlock

* AMERISOURCEBERGEN SELECTED BY DECIPHERA PHARMACEUTICALS TO SUPPORT QINLOCK™ Source text for Eikon: Further company coverage:

BRIEF-AmerisourceBergen Corp Prices $500 Mln 2.800% Senior Notes Due 2030

* AMERISOURCEBERGEN PRICES $500 MILLION 2.800% SENIOR NOTES DUE 2030 Source text for Eikon: Further company coverage:

BRIEF-Amerisourcebergen Sees 2020 Rev Growth In Low- To Mid-Single Digit Percent Range

* AMERISOURCEBERGEN REPORTS FISCAL 2020 SECOND QUARTER RESULTS

Exclusive: AmerisourceBergen eyes Walgreens' drug distribution business

AmerisourceBergen Corp <ABC.N>, one of the largest U.S. drug distributors, has approached Walgreens Boots Alliance Inc <WBA.O> to explore a deal for its pharmaceutical wholesaling division, people familiar with the matter said on Monday.

BRIEF-PIRC Recommends Amerisourcebergen Shareholders To Vote Against Election Of Steven H Collis As Director

* PROXY ADVISORY FIRM PIRC RECOMMENDS AMERISOURCEBERGEN CORP SHAREHOLDERS TO VOTE AGAINST RESOLUTION TO ELECT CEO STEVEN H COLLIS AS DIRECTOR

Dela. judge okays Supreme Court review of controversial books-and-records decision

Vice-Chancellor Travis Laster of Delaware Chancery Court signaled Wednesday that he really did intend to reset the course of books-and-records litigation when he ruled last month that the wholesale pharmaceutical distributor AmerisourceBergen give shareholders formal board...

Delaware Chancery judge pushes back against limits on books-and-records demands

There is a reasonable possibility, according to Vice-Chancellor Travis Laster, that shareholders of the wholesale pharmaceutical distributor AmerisourceBergen Corporation will turn out to have an actionable claim that the company’s directors breached their fiduciary duties...

AmerisourceBergen loses bid to keep parts of N.Y. opioid case secret

AmerisourceBergen has lost a bid to keep secret material related to the drug distributor's internal program for monitoring for suspicious orders in a lawsuit by New York's attorney general accusing the company of fueling the opioid epidemic.

AmerisourceBergen to pay $625 million in U.S. civil fraud settlement

AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.

AmerisourceBergen in $625 mln drug distribution settlement, New York says

AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.

UPDATE 1-U.S. subpoenas AmerisourceBergen over opioid products

Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

U.S. subpoenas AmerisourceBergen over opioid products

Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up